Viewing Study NCT04232332


Ignite Creation Date: 2025-12-24 @ 9:58 PM
Ignite Modification Date: 2026-03-09 @ 2:28 AM
Study NCT ID: NCT04232332
Status: UNKNOWN
Last Update Posted: 2021-08-17
First Post: 2020-01-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Phase I Study of Recombinant Human Nerve Growth Factor Injection
Sponsor: Beijing Tongren Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Injury of Optic Nerve View
Keywords: